Latest Period
Q1 2026
Security Snapshot
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) Institutional Ownership
CUSIP: 19188J409
13F Institutional Holders and Ownership History from Q4 2022 to Q1 2026
Institutions Reporting
25
Shares (Excl. Options)
776,191
Price
$1.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- COCP on Nasdaq
- Shares outstanding
- 13,831,528
- Price per share
- $1.39
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 776,191
- Total reported value
- $783,754
- % of total 13F portfolios
- 0%
- Share change
- +5,701
- Value change
- +$6,975
- Number of holders
- 25
- Price from insider filings
- $1.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 19188J409.
- 25 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 26 to 25 between Q4 2025 and Q1 2026.
- Reported value moved from $754,323 to $783,754.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 25 institutions filings for Q1 2026.
Security key
19188J409
Latest holder period
Q1 2026
13F holders
25
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
COCP full holder history
Cocrystal Pharma, Inc. SEC filings
Cocrystal Pharma, Inc. company facts
Cocrystal Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19188J409:
Significant Owners of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | 18% | +65% | $3,078,992 | +$1,349,571 | 2,462,012 | +78% | Phillip Frost, M.D. | 28 Oct 2025 |
As of 31 Mar 2026, 25 institutional investors reported holding 776,191 shares of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP). This represents 5.6% of the company’s total 13,831,528 outstanding shares.
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 776,191 | $783,754 | +$6,975 | $1.01 | 25 |
| 2025 Q4 | 770,490 | $754,323 | +$52,087 | $0.98 | 26 |
| 2025 Q3 | 664,982 | $831,248 | -$40,108 | $1.25 | 21 |
| 2025 Q2 | 686,516 | $1,022,928 | -$87,903 | $1.49 | 21 |
| 2025 Q1 | 748,773 | $1,064,069 | +$47,078 | $1.42 | 23 |
| 2024 Q4 | 711,389 | $1,437,038 | -$15,989 | $2.02 | 23 |
| 2024 Q3 | 719,274 | $1,265,944 | +$79,057 | $1.76 | 19 |
| 2024 Q2 | 674,355 | $1,571,278 | -$90,505 | $2.33 | 13 |
| 2024 Q1 | 721,322 | $1,013,555 | +$53,963 | $1.40 | 14 |
| 2023 Q4 | 683,341 | $1,173,672 | -$35,542 | $1.72 | 16 |
| 2023 Q3 | 704,225 | $1,316,878 | +$61,523 | $1.87 | 15 |
| 2023 Q2 | 666,895 | $1,594,259 | -$144,985 | $2.39 | 19 |
| 2023 Q1 | 738,638 | $1,468,069 | -$651,598 | $1.99 | 19 |
| 2022 Q4 | 1,065,912 | $2,076,645 | +$2,076,610 | $1.95 | 18 |